Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.

Florholmen J.

Scand J Gastroenterol. 2015 Jan;50(1):43-52. doi: 10.3109/00365521.2014.977943.

PMID:
25523555
2.

Achievements and challenges in the management of inflammatory bowel disease.

Florholmen J, Sandvik A.

Scand J Gastroenterol. 2015 Jan;50(1):1-2. doi: 10.3109/00365521.2014.992948. No abstract available.

PMID:
25523550
3.

Risk of malnutrition and zinc deficiency in community-living elderly men and women: the Tromsø Study.

Kvamme JM, Grønli O, Jacobsen BK, Florholmen J.

Public Health Nutr. 2014 Nov 6:1-7. [Epub ahead of print]

PMID:
25373445
4.

Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.

Cui G, Qi H, Gundersen MD, Yang H, Christiansen I, Sørbye SW, Goll R, Florholmen J.

Cancer Immunol Immunother. 2015 Feb;64(2):181-90. doi: 10.1007/s00262-014-1624-x. Epub 2014 Oct 17.

PMID:
25324197
5.

Cellular and molecular mediators of intestinal fibrosis.

Lawrance IC, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, Reif S, Speca S, Latella G.

J Crohns Colitis. 2014 Oct 8. pii: S1873-9946(14)00289-X. doi: 10.1016/j.crohns.2014.09.008. [Epub ahead of print] Review.

PMID:
25306501
6.

Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice.

Qi H, Yang H, Xu G, Ren J, Hua W, Shi Y, Torsvik M, Florholmen J, Cui G.

Immunobiology. 2015 Jan;220(1):54-9. doi: 10.1016/j.imbio.2014.09.002. Epub 2014 Sep 8.

PMID:
25239511
7.

Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence.

Cui G, Yang H, Zhao J, Yuan A, Florholmen J.

Pathol Oncol Res. 2015 Jan;21(1):139-46. doi: 10.1007/s12253-014-9799-1. Epub 2014 May 25.

PMID:
24859972
8.

Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.

Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, Reif S, Speca S, Lawrance IC.

J Crohns Colitis. 2014 Oct 1;8(10):1147-65. doi: 10.1016/j.crohns.2014.03.008. Epub 2014 Apr 14.

9.

Vedolizumab as induction and maintenance therapy for Crohn's disease.

Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group.

N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739.

10.

Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group.

N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.

11.

Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test.

Berg LK, Fagerli E, Martinussen M, Myhre AO, Florholmen J, Goll R.

Scand J Gastroenterol. 2013 Aug;48(8):936-43. doi: 10.3109/00365521.2013.812139. Epub 2013 Jul 8.

PMID:
23834159
12.

The role of interleukin-17A in colorectal tumorigenesis.

Shi Y, Lin H, Cui J, Qi H, Florholmen J, Liu Z, Cui G.

Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):429-32. doi: 10.1089/cbr.2012.1396. Epub 2013 May 23. Review.

PMID:
23701420
13.

Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.

Rismo R, Olsen T, Cui G, Paulssen EJ, Christiansen I, Johnsen K, Florholmen J, Goll R.

Scand J Gastroenterol. 2013 Mar;48(3):311-9. doi: 10.3109/00365521.2012.758773. Epub 2013 Jan 10.

PMID:
23302000
14.

The expression of non-mast histamine in tumor associated microvessels in human colorectal cancers.

Cui J, Xu G, Liu J, Pang Z, Florholmen J, Cui G.

Pathol Oncol Res. 2013 Apr;19(2):311-6. doi: 10.1007/s12253-012-9584-y. Epub 2012 Dec 14.

PMID:
23239191
15.

Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional.

Johanson V, Wilson B, Abrahamsson A, Jianu C, Calissendorff J, Wall N, Grønbæk H, Florholmen J, Ohberg A, Granberg D.

Patient Prefer Adherence. 2012;6:703-10. doi: 10.2147/PPA.S34337. Epub 2012 Oct 17.

16.

Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway.

Breckan RK, Asfeldt AM, Straume B, Florholmen J, Paulssen EJ.

Scand J Gastroenterol. 2012 Nov;47(11):1274-82. doi: 10.3109/00365521.2012.688215.

PMID:
23061445
17.

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.

Fiocca R, Mastracci L, Attwood SE, Ell C, Galmiche JP, Hatlebakk J, Bärthel A, Långström G, Lind T, Lundell L; LOTUS trial collaborators.

Aliment Pharmacol Ther. 2012 Nov;36(10):959-71. doi: 10.1111/apt.12052. Epub 2012 Sep 23.

PMID:
22998687
18.

IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.

Cui G, Yuan A, Goll R, Florholmen J.

Scand J Gastroenterol. 2012 Nov;47(11):1304-12. doi: 10.3109/00365521.2012.725089. Epub 2012 Sep 19.

PMID:
22989213
19.

The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease.

Rismo R, Olsen T, Ciu G, Paulssen EJ, Christiansen I, Florholmen J, Goll R.

Scand J Gastroenterol. 2012 Oct;47(10):1200-10. Epub 2012 Aug 6.

PMID:
22861799
20.

Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome.

Birketvedt GS, Geliebter A, Kristiansen I, Firgenschau Y, Goll R, Florholmen JR.

Appetite. 2012 Dec;59(3):688-92. doi: 10.1016/j.appet.2012.07.015. Epub 2012 Jul 27.

PMID:
22841814
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk